15-HEPE Compositions for Hematologic Disorder Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hematologic disorders, such as anemia and thrombophilia, often fail to effectively address the underlying issues of red blood cell production and coagulation abnormalities, leading to inadequate oxygen transport and increased risk of blood clots.
Innovation Solution
Administration of compositions comprising 15-hydroxyeicosapentaenoic acid (15-HEPE), which represents at least 90% of the fatty acids, to promote increases in red blood cell count, decrease red cell distribution width, and normalize coagulation parameters, thereby treating and preventing hematologic disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for hematologic disorders are used, then conventional therapy is provided, but red blood cell production and coagulation abnormalities are not effectively addressed
Solution Approach 1:
The patent changes the chemical parameter by introducing 15-HEPE, a specific fatty acid derivative, to alter red blood cell membrane composition and coagulation pathway parameters. This biochemical parameter change addresses the underlying mechanisms of hematologic disorders rather than treating symptoms, thereby improving treatment reliability while reducing harmful effects of inadequate oxygen transport and abnormal coagulation
2Quantity of substance
If 15-HEPE compositions are administered to increase red blood cell count, then oxygen transport is improved, but treatment complexity increases
Solution Approach 1:
The patent extracts and isolates the specific active component 15-HEPE from complex fatty acid mixtures, creating a purified composition that targets red blood cell production specifically. This extraction approach increases red blood cell count through a single well-defined substance rather than complex multi-component treatments, thereby improving quantity of red blood cells while actually reducing treatment complexity through specification and purification
3Stability of the object's composition
If 15-HEPE is used to decrease red cell distribution width, then red blood cell uniformity is improved, but manufacturing precision of the composition becomes critical
Solution Approach 1:
The patent establishes specific parameter ranges for 15-HEPE composition (at least 90% purity) and controls biochemical parameters during administration to achieve uniform red blood cell characteristics. By defining and controlling these parameters, the patent improves red cell distribution width while providing clear manufacturing specifications that make precision achievable through standardized production protocols
Data Source
AI summary
The present disclosure relates to methods of treating or preventing hematologic disorders by administration of 15-HEPE or compositions thereof.